Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy

Currently the greatest challenge in oncology is the lack of homogeneity of the lesions where different cell components respond differently to treatment. There is growing consensus that monotherapies are insufficient to eradicate the disease and there is an unmet need for more potent combinatorial tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Theodossiou, Theodossis A., Ali, Muhammad, Grigalavicius, Mantas, Grallert, Beata, Dillard, Pierre, Schink, Kay Oliver, Olsen, Cathrine E., Wälchli, Sébastien, Inderberg, Else Marit, Kubin, Andreas, Peng, Qian, Berg, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458138/
https://www.ncbi.nlm.nih.gov/pubmed/30993194
http://dx.doi.org/10.1038/s41523-019-0108-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458138/
https://www.ncbi.nlm.nih.gov/pubmed/30993194
http://dx.doi.org/10.1038/s41523-019-0108-8

Ejemplares similares